Intra-Cellular Therapies
ITCI
Reported
Wednesday, March 1
Q4 2022 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -0.59 | -0.45 | 0.14 | 23.73% |
| Revenue | 87.0M | 87.9M | 899K | 1.03% |
WhatIF - Earnings
EPS Beat Expectations by $0.14
Intra-Cellular Therapies (ITCI:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything